In just the last 2 years there have been updates in classification, risk assessment, and response criteria in myelodysplastic syndromes (MDS), but additional efforts are needed to improve these, and ...
Authors acknowledge that both the 2022 World Health Organization and International Consensus Classification myelodysplastic syndrome criteria sets have value, while sorting out their similarities and ...
•Genomic characterization determines diagnosis, classification, and prognostication of the myeloid malignancies myelodysplastic syndrome (MDS) and AML. •Recognizing genetic lesions as invariable ...
—Classifying myelodysplastic syndrome and secondary acute myeloid leukemia by genetic mutations rather than strictly by blast count may allow more patients to be eligible for AML and MDS clinical ...
The classification system for this type of cancer aims to help define, diagnose, and treat the disease and improve outcomes. Myelodysplastic syndromes (MDSs), which are now also called myelodysplastic ...
Deep in the bone marrow lies the reason for blood disorders classified as myelodysplastic syndromes—stem cells gone awry. In the mid-1970s, a group of pathologists and clinicians from around the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback